| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Pluri Inc. (PLUR) has 7 insiders with recent SEC Form 4 filings, including 7 buys and 4 sells. PLUR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 625.0K | $2.09M | - | |
| CEO | 497.8K | $1.67M | - | |
| Dir | 144.2K | $483.1K | - | |
| CFO | 92.8K | $310.8K | - | |
| Dir | 19.1K | $64.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 8, 2019 | Ben-Yoram Israel | Director | Buy | 71,429 | $0.70 | $50,000.30 | +22.6% | |
| Apr 8, 2019 | Yanay Yaky | Co-ceo &President | Buy | 71,429 | $0.70 | $50,000.30 | +1.7% | |
| Apr 8, 2019 | Aberman Zami | Co-ceo &Chairman | Buy | 71,429 | $0.70 | $50,000.30 | +1.5% | |
| Apr 8, 2019 | Kwiat Moria | Director | Buy | 28,571 | $0.70 | $19,999.70 | +8.3% | |
| Apr 8, 2019 | Shorrer Doron | Director | Buy | 14,286 | $0.70 | $10,000.20 | +3.2% | |
| Apr 8, 2019 | Braun Isaac | Director | Buy | 50,000 | $0.70 | $35,000.00 | +8.5% | |
| Mar 16, 2018 | Germain Mark | Director | Sell | 45,873 | $1.48 | $67,892.04 | -4.2% | |
| Mar 14, 2018 | Germain Mark | Director | Sell | 23,818 | $1.50 | $35,727.00 | -4.1% | |
| May 30, 2016 | Shorrer Doron | Director | Sell | 12,346 | $1.52 | $18,784.44 | -2.1% | |
| Feb 22, 2016 | Aberman Zami | CEO &Chairman | Buy | 5,000 | $1.33 | $6,650.00 | +4.7% |